Literature DB >> 31085

Azulfidine- (sulfasalazine-) induced hepatic injury.

R S Kanner, F J Tedesco, M H Kalser.   

Abstract

A patient with Azulfidine-related hepatotoxicity in which prompt recurrence of symptoms, fever skin rash, and laboratory evidence of hepatocellular injury occurred upon readministration of Azulfidine is reported. The clinical and biochemical features support the fact that this was an example of an acquired hypersensitivity reaction to Azulfidine.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 31085     DOI： 10.1007/bf01072475

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


  8 in total

1.  Focal hepatitis, fever and skin rash following therapy with sulfamethoxypyridazine, a long-acting sulfonamide.

Authors:  W A TISDALE
Journal:  N Engl J Med       Date:  1958-04-03       Impact factor: 91.245

2.  Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole.

Authors:  C A Dujovne; C H Chan; H J Zimmerman
Journal:  N Engl J Med       Date:  1967-10-12       Impact factor: 91.245

3.  Sulfonamide-induced chronic liver disease.

Authors:  M Tönder; A Nordöy; K Elgjo
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

4.  Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy.

Authors:  T Han; P L Chawla; J E Sokal
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

5.  Granulomatous hepatitis associated with sulfadimethoxine hypersensitivity.

Authors:  C R Espiritu; T S Kim; R A Levine
Journal:  JAMA       Date:  1967-12-04       Impact factor: 56.272

6.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

7.  Systemic granulomatous reaction to salicylazosulfapyridine (Azulfidine) in a patient with Crohn's disease.

Authors:  R J Rafoth
Journal:  Am J Dig Dis       Date:  1974-05

8.  Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors:  J R Collins
Journal:  South Med J       Date:  1968-04       Impact factor: 0.954
  8 in total
  4 in total

Review 1.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 2.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 3.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

4.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.